During the past decade, McIlwain Medical Group, PA conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 14 clinical trials were completed, i.e. on average, 127.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McIlwain Medical Group, PA" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 2 trials, followed by "R-Pharm International, LLC" with 2 trials sponsored, "Sandoz" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "EMD Serono" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McIlwain Medical Group, PA" #1 collaborator was "Hexal AG" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "McIlwain Medical Group, PA" are "Rheumatoid Arthritis" (8 trials), "Lupus Erythematosus, Systemic" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "McIlwain Medical Group, PA" in a lesser frequency.

Most popular intervention types in "McIlwain Medical Group, PA" are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Adalimumab" (2 trials), "Adalimumab - GP2017" (1 trials), "Adalimumab - US licensed Humira" (1 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.

The vast majority of trials in "McIlwain Medical Group, PA" are 15 trials for "All" genders.

Currently, there are NaN active trials in "McIlwain Medical Group, PA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in McIlwain Medical Group, PA, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in McIlwain Medical Group, PA, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".